|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,684,301 |
|
|
Indirect Value
|
$12,931,100,738 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,012,785,039 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 44 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2006-06-27 |
4 |
B |
$4.03 |
$394,570 |
I/I |
97,745 |
3,415,877 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-20 |
4 |
B |
$14.51 |
$395,875 |
I/I |
27,272 |
4,672,660 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$397,796 |
I/I |
(30,734) |
956,958 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-05 |
4 |
B |
$13.88 |
$398,315 |
I/I |
28,685 |
317,452 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-22 |
4 |
B |
$4.88 |
$399,094 |
I/I |
79,401 |
173,450 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$402,984 |
I/I |
24,655 |
1,068,923 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-10 |
4 |
B |
$19.48 |
$408,036 |
I/I |
20,934 |
3,690,370 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$410,220 |
I/I |
32,630 |
1,215,554 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-06 |
4 |
S |
$12.62 |
$410,982 |
I/I |
(32,508) |
312,441 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$413,293 |
I/I |
(19,030) |
140,977 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-26 |
4 |
B |
$4.00 |
$414,374 |
I/I |
103,552 |
3,318,132 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-11 |
4 |
B |
$14.71 |
$415,465 |
I/I |
28,206 |
4,493,192 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-20 |
4 |
B |
$6.50 |
$421,324 |
I/I |
64,825 |
6,647,929 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$423,038 |
I/I |
52,736 |
7,937,438 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$425,038 |
I/I |
68,006 |
539,130 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-28 |
4 |
B |
$5.50 |
$425,222 |
I/I |
77,313 |
1,718,794 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-11 |
4 |
B |
$4.03 |
$429,591 |
I/I |
106,622 |
4,112,541 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$430,371 |
I/I |
(21,445) |
25,983 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-29 |
4 |
S |
$12.47 |
$431,430 |
I/I |
(34,606) |
1,362,382 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$432,557 |
I/I |
26,373 |
1,044,268 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-19 |
4 |
B |
$6.75 |
$433,973 |
I/I |
64,259 |
6,583,104 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-13 |
4 |
B |
$8.69 |
$435,755 |
I/I |
50,130 |
5,002,636 |
1.5 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$439,185 |
I/I |
34,934 |
1,691,130 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-01-27 |
4 |
B |
$6.98 |
$441,971 |
I/I |
63,345 |
12,616,525 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-22 |
4 |
B |
$4.88 |
$444,365 |
I/I |
88,408 |
190,325 |
2.25 |
- |
|
1397 Records found
|
|
Page 44 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|